Skip to main content

Microneedle-assisted nanovector skin patch for immunomodulation of the inflammatory response upon occurrence of myocardial infarction injury (MiNeMi)

Project description

Immune system modulation after myocardial infarction

Current treatment strategies for ischaemic heart disease only ameliorate symptoms. The EU-funded MiNeMI project is working on a novel immunomodulatory approach that aims to regulate inflammation and promote heart regeneration after myocardial infarction. Researchers are developing a non-invasive microneedle-based skin patch loaded with both immunomodulatory and biological molecules. The idea is to release these therapeutics into the dermal layer of the skin where a reservoir of immune cells resides. The efficacy and safety of the MiNeMI approach will be tested in vitro and in an animal model of cardiac ischaemia.


Net EU contribution
€ 190 680,96
Yliopistonkatu 3
00014 Helsingin Yliopisto

See on map

Manner-Suomi Helsinki-Uusimaa Helsinki-Uusimaa
Activity type
Higher or Secondary Education Establishments
Other funding
€ 0,00